Home About us Current issue Ahead of Print Back issues Submission Instructions Advertise Contact Login   

Search Article 
Advanced search 
Saudi Journal of Kidney Diseases and Transplantation
Users online: 1520 Home Bookmark this page Print this page Email this page Small font sizeDefault font size Increase font size 

Year : 2010  |  Volume : 21  |  Issue : 3  |  Page : 548-554
Prevention of hepatitis C virus in hemodialysis patients: Five years experience from a single center

Nephrology Division, Medical Department, Dawmat Aljandal General Hospital, Aljouf, Saudi Arabia

Correspondence Address:
Waleed Z Mohamed
Nephrology Division, Medical Department, Dawmat Aljandal General Hospital, Dawmat Aljandal, Aljouf
Saudi Arabia
Login to access the Email id

Source of Support: None, Conflict of Interest: None

PMID: 20427892

Rights and PermissionsRights and Permissions

Hepatitis C virus (HCV) has been a significant problem in hemodialysis (HD) pa­tients. In general, it carries significant morbidity including liver cirrhosis, liver cell failure and hepa­toma. The study was conducted on 36 seronegative HD patients. All patients were managed with strict application of infection control guidelines as well as isolation of HCV-positive patients. None of the patients received any blood transfusions and were managed with iron and erythro­poietin. After five years of follow-up, we found that the incidence of HCV seroconversion was zero. Our study further suggests that following infection control guidelines, isolation of sero­positive patients and minimizing blood transfusions can help in prevention of HCV transmission among HD patients.

Print this article  Email this article

  Similar in PUBMED
    Search Pubmed for
    Search in Google Scholar for
   Citation Manager
  Access Statistics
   Reader Comments
   Email Alert *
   Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded803    
    Comments [Add]    
    Cited by others 7    

Recommend this journal